Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 104

1.

Air disinfection in measles transmission hotspots.

Nardell E, Nathavitharana R.

Lancet. 2019 Sep 5. pii: S0140-6736(19)31889-6. doi: 10.1016/S0140-6736(19)31889-6. [Epub ahead of print] No abstract available.

PMID:
31495498
2.

The Lancet Respiratory Medicine Commission: 2019 update: epidemiology, pathogenesis, transmission, diagnosis, and management of multidrug-resistant and incurable tuberculosis.

Dheda K, Gumbo T, Maartens G, Dooley KE, Murray M, Furin J, Nardell EA, Warren RM; Lancet Respiratory Medicine drug-resistant tuberculosis Commission group.

Lancet Respir Med. 2019 Sep;7(9):820-826. doi: 10.1016/S2213-2600(19)30263-2. Review.

PMID:
31486393
3.

Treatment as prevention and other interventions to reduce transmission of multidrug-resistant tuberculosis.

Nathavitharana RR, Lederer P, Tierney DB, Nardell E.

Int J Tuberc Lung Dis. 2019 Apr 1;23(4):396-404. doi: 10.5588/ijtld.18.0276.

PMID:
31064617
4.

Reducing tuberculosis transmission: a consensus document from the World Health Organization Regional Office for Europe.

Migliori GB, Nardell E, Yedilbayev A, D'Ambrosio L, Centis R, Tadolini M, van den Boom M, Ehsani S, Sotgiu G, Dara M.

Eur Respir J. 2019 Jun 5;53(6). pii: 1900391. doi: 10.1183/13993003.00391-2019. Print 2019 Jun.

PMID:
31023852
5.

Process measure of FAST tuberculosis infection control demonstrates delay in likely effective treatment.

Le H, Nguyen N, Tran P, Hoa N, Hung N, Moran A, Mossawi HJA, Kak N, Ahmedov S, Brooks MB, Nardell EA, Tierney DB.

Int J Tuberc Lung Dis. 2019 Feb 1;23(2):140-146. doi: 10.5588/ijtld.18.0268. Epub 2019 Jan 8.

PMID:
30621813
6.

Transmission of drug-resistant tuberculosis in HIV-endemic settings.

Khan PY, Yates TA, Osman M, Warren RM, van der Heijden Y, Padayatchi N, Nardell EA, Moore D, Mathema B, Gandhi N, Eldholm V, Dheda K, Hesseling AC, Mizrahi V, Rustomjee R, Pym A.

Lancet Infect Dis. 2019 Mar;19(3):e77-e88. doi: 10.1016/S1473-3099(18)30537-1. Epub 2018 Dec 13. Review. Erratum in: Lancet Infect Dis. 2019 Mar 6;:.

7.

Tuberculosis.

Bloom BR, Atun R, Cohen T, Dye C, Fraser H, Gomez GB, Knight G, Murray M, Nardell E, Rubin E, Salomon J, Vassall A, Volchenkov G, White R, Wilson D, Yadav P.

In: Holmes KK, Bertozzi S, Bloom BR, Jha P, editors. Major Infectious Diseases. 3rd edition. Washington (DC): The International Bank for Reconstruction and Development / The World Bank; 2017 Nov 3. Chapter 11.

8.

Droplets, dust and guinea pigs: an historical review of tuberculosis transmission research, 1878-1940.

Donald PR, Diacon AH, Lange C, Demers AM, von Groote-Bidlingmaier F, Nardell E.

Int J Tuberc Lung Dis. 2018 Sep 1;22(9):972-982. doi: 10.5588/ijtld.18.0173. Review. Erratum in: Int J Tuberc Lung Dis. 2018 Oct 1;22(10):1244.

PMID:
30092861
9.

Designing and Evaluating Interventions to Halt the Transmission of Tuberculosis.

Dowdy DW, Grant AD, Dheda K, Nardell E, Fielding K, Moore DAJ.

J Infect Dis. 2017 Nov 3;216(suppl_6):S654-S661. doi: 10.1093/infdis/jix320. Review.

10.

FAST implementation in Bangladesh: high frequency of unsuspected tuberculosis justifies challenges of scale-up.

Nathavitharana RR, Daru P, Barrera AE, Mostofa Kamal SM, Islam S, Ul-Alam M, Sultana R, Rahman M, Hossain MS, Lederer P, Hurwitz S, Chakraborty K, Kak N, Tierney DB, Nardell E.

Int J Tuberc Lung Dis. 2017 Sep 1;21(9):1020-1025. doi: 10.5588/ijtld.16.0794.

11.

The epidemiology, pathogenesis, transmission, diagnosis, and management of multidrug-resistant, extensively drug-resistant, and incurable tuberculosis.

Dheda K, Gumbo T, Maartens G, Dooley KE, McNerney R, Murray M, Furin J, Nardell EA, London L, Lessem E, Theron G, van Helden P, Niemann S, Merker M, Dowdy D, Van Rie A, Siu GK, Pasipanodya JG, Rodrigues C, Clark TG, Sirgel FA, Esmail A, Lin HH, Atre SR, Schaaf HS, Chang KC, Lange C, Nahid P, Udwadia ZF, Horsburgh CR Jr, Churchyard GJ, Menzies D, Hesseling AC, Nuermberger E, McIlleron H, Fennelly KP, Goemaere E, Jaramillo E, Low M, Jara CM, Padayatchi N, Warren RM.

Lancet Respir Med. 2017 Mar 15. pii: S2213-2600(17)30079-6. doi: 10.1016/S2213-2600(17)30079-6. [Epub ahead of print] Review.

PMID:
28344011
12.

Agents of change: The role of healthcare workers in the prevention of nosocomial and occupational tuberculosis.

Nathavitharana RR, Bond P, Dramowski A, Kotze K, Lederer P, Oxley I, Peters JA, Rossouw C, van der Westhuizen HM, Willems B, Ting TX, von Delft A, von Delft D, Duarte R, Nardell E, Zumla A.

Presse Med. 2017 Mar;46(2 Pt 2):e53-e62. doi: 10.1016/j.lpm.2017.01.014. Epub 2017 Feb 28. Review.

13.

Engaging health-care workers to reduce tuberculosis transmission.

Nathavitharana RR, Peters J, Lederer P, von Delft A, Farley JE, Pai M, Jaramillo E, Raviglione M, Nardell E.

Lancet Infect Dis. 2016 Aug;16(8):883-5. doi: 10.1016/S1473-3099(16)30199-2. No abstract available.

PMID:
27477968
14.

Infection Control for Drug-Resistant Tuberculosis: Early Diagnosis and Treatment Is the Key.

van Cutsem G, Isaakidis P, Farley J, Nardell E, Volchenkov G, Cox H.

Clin Infect Dis. 2016 May 15;62 Suppl 3:S238-43. doi: 10.1093/cid/ciw012.

15.

Occupant UV exposure measurements for upper-room ultraviolet germicidal irradiation.

Milonova S, Rudnick S, McDevitt J, Nardell E.

J Photochem Photobiol B. 2016 Jun;159:88-92. doi: 10.1016/j.jphotobiol.2016.03.009. Epub 2016 Mar 11.

16.

Inhaled drug treatment for tuberculosis: Past progress and future prospects.

Hickey AJ, Durham PG, Dharmadhikari A, Nardell EA.

J Control Release. 2016 Oct 28;240:127-134. doi: 10.1016/j.jconrel.2015.11.018. Epub 2015 Nov 18. Review.

PMID:
26596254
17.

Turning off the tap: stopping tuberculosis transmission through active case-finding and prompt effective treatment.

Yuen CM, Amanullah F, Dharmadhikari A, Nardell EA, Seddon JA, Vasilyeva I, Zhao Y, Keshavjee S, Becerra MC.

Lancet. 2015 Dec 5;386(10010):2334-43. doi: 10.1016/S0140-6736(15)00322-0. Epub 2015 Nov 4. Review.

PMID:
26515675
18.

Transmission and Institutional Infection Control of Tuberculosis.

Nardell EA.

Cold Spring Harb Perspect Med. 2015 Aug 20;6(2):a018192. doi: 10.1101/cshperspect.a018192. Review.

19.

Indoor environmental control of tuberculosis and other airborne infections.

Nardell EA.

Indoor Air. 2016 Feb;26(1):79-87. doi: 10.1111/ina.12232. Epub 2015 Oct 7.

PMID:
26178270
20.

The antimicrobial effect of colistin methanesulfonate on Mycobacterium tuberculosis in vitro.

van Breda SV, Buys A, Apostolides Z, Nardell EA, Stoltz AC.

Tuberculosis (Edinb). 2015 Jul;95(4):440-6. doi: 10.1016/j.tube.2015.05.005. Epub 2015 May 21.

PMID:
26038290
21.

Institutional Tuberculosis Transmission. Controlled Trial of Upper Room Ultraviolet Air Disinfection: A Basis for New Dosing Guidelines.

Mphaphlele M, Dharmadhikari AS, Jensen PA, Rudnick SN, van Reenen TH, Pagano MA, Leuschner W, Sears TA, Milonova SP, van der Walt M, Stoltz AC, Weyer K, Nardell EA.

Am J Respir Crit Care Med. 2015 Aug 15;192(4):477-84. doi: 10.1164/rccm.201501-0060OC.

22.

F-A-S-T: a refocused, intensified, administrative tuberculosis transmission control strategy.

Barrera E, Livchits V, Nardell E.

Int J Tuberc Lung Dis. 2015 Apr;19(4):381-4. doi: 10.5588/ijtld.14.0680. Review. No abstract available.

PMID:
25859991
23.

Rapid impact of effective treatment on transmission of multidrug-resistant tuberculosis.

Dharmadhikari AS, Mphahlele M, Venter K, Stoltz A, Mathebula R, Masotla T, van der Walt M, Pagano M, Jensen P, Nardell E.

Int J Tuberc Lung Dis. 2014 Sep;18(9):1019-25. doi: 10.5588/ijtld.13.0834.

24.

Influence of Bioaerosol Source Location and Ceiling Fan Direction on Eggcrate Upper-room Ultraviolet Germicidal Irradiation.

Rahman SF, Rudnick SN, Milonova SP, McDevitt JJ, Nardell EA.

Br J Appl Sci Technol. 2014 Sep;4(26):3856-3861. Epub 2014 Jul 20.

25.

Multidrug-resistant tuberculosis. Recommendations for reducing risk during travel for healthcare and humanitarian work.

Seaworth BJ, Armitige LY, Aronson NE, Hoft DF, Fleenor ME, Gardner AF, Harris DA, Stricof RL, Nardell EA.

Ann Am Thorac Soc. 2014 Mar;11(3):286-95. doi: 10.1513/AnnalsATS.201309-312PS.

PMID:
24673692
26.

Mycobacteria inactivation using Engineered Water Nanostructures (EWNS).

Pyrgiotakis G, McDevitt J, Gao Y, Branco A, Eleftheriadou M, Lemos B, Nardell E, Demokritou P.

Nanomedicine. 2014 Aug;10(6):1175-83. doi: 10.1016/j.nano.2014.02.016. Epub 2014 Mar 12.

27.

Numerical Modeling of Indoor Environment with a Ceiling Fan and an Upper-Room Ultraviolet Germicidal Irradiation System.

Zhu S, Srebric J, Rudnick SN, Vincent RL, Nardell EA.

Build Environ. 2014 Feb;72:116-124.

28.

Aspiring to zero tuberculosis deaths among southern Africa's miners: is there a way forward?

Dharmadhikari A, Smith J, Nardell E, Churchyard G, Keshavjee S.

Int J Health Serv. 2013;43(4):651-64.

PMID:
24397232
29.

Interferon γ-release assays for diagnosis of latent tuberculosis in healthcare workers in low-incidence settings: pros and cons.

Pollock NR, McAdam AJ, Pai M, Nardell EA, Bernardo J, Banaei N, Mobo J.

Clin Chem. 2014 May;60(5):714-8. doi: 10.1373/clinchem.2012.201178. Epub 2013 Oct 7. No abstract available.

30.

Eggcrate UV: a whole ceiling upper-room ultraviolet germicidal irradiation system for air disinfection in occupied rooms.

Linnes JC, Rudnick SN, Hunt GM, McDevitt JJ, Nardell EA.

Indoor Air. 2014 Apr;24(2):116-24. doi: 10.1111/ina.12063. Epub 2013 Oct 21.

PMID:
23889191
31.

Upper-room ultraviolet germicidal irradiation (UVGI) for air disinfection: a symposium in print.

Nardell E, Vincent R, Sliney DH.

Photochem Photobiol. 2013 Jul-Aug;89(4):764-9. doi: 10.1111/php.12098.

PMID:
23683092
32.

Phase I, single-dose, dose-escalating study of inhaled dry powder capreomycin: a new approach to therapy of drug-resistant tuberculosis.

Dharmadhikari AS, Kabadi M, Gerety B, Hickey AJ, Fourie PB, Nardell E.

Antimicrob Agents Chemother. 2013 Jun;57(6):2613-9. doi: 10.1128/AAC.02346-12. Epub 2013 Mar 25.

33.

Numerical investigation of upper-room UVGI disinfection efficacy in an environmental chamber with a ceiling fan.

Zhu S, Srebric J, Rudnick SN, Vincent RL, Nardell EA.

Photochem Photobiol. 2013 Jul-Aug;89(4):782-91. doi: 10.1111/php.12039. Epub 2013 Jan 30.

34.

A radiometry protocol for UVGI fixtures using a moving-mirror type gonioradiometer.

Zhang J, Levin R, Angelo R, Vincent R, Brickner P, Ngai P, Nardell EA.

J Occup Environ Hyg. 2012;9(3):140-8. doi: 10.1080/15459624.2011.648569.

PMID:
22332869
35.

Surgical face masks worn by patients with multidrug-resistant tuberculosis: impact on infectivity of air on a hospital ward.

Dharmadhikari AS, Mphahlele M, Stoltz A, Venter K, Mathebula R, Masotla T, Lubbe W, Pagano M, First M, Jensen PA, van der Walt M, Nardell EA.

Am J Respir Crit Care Med. 2012 May 15;185(10):1104-9. doi: 10.1164/rccm.201107-1190OC. Epub 2012 Feb 9.

36.

Programmatic management of multidrug-resistant tuberculosis--15 years later.

Nardell EA.

Int J Tuberc Lung Dis. 2011 Oct;15(10):1280. doi: 10.5588/ijtld.11.0604. No abstract available.

PMID:
22283883
37.

What is thwarting tuberculosis prevention in high-burden settings?

Nardell E, Churchyard G.

N Engl J Med. 2011 Jul 7;365(1):79-81. doi: 10.1056/NEJMe1105555. No abstract available.

38.

Natural infection of guinea pigs exposed to patients with highly drug-resistant tuberculosis.

Dharmadhikari AS, Basaraba RJ, Van Der Walt ML, Weyer K, Mphahlele M, Venter K, Jensen PA, First MW, Parsons S, McMurray DN, Orme IM, Nardell EA.

Tuberculosis (Edinb). 2011 Jul;91(4):329-38. doi: 10.1016/j.tube.2011.03.002. Epub 2011 Apr 7.

39.

Serial acid fast bacilli smear and culture conversion rates over 26 weeks in a cohort of 93 sputum culture–positive tuberculosis (TB).

Dharmadhikari AS, Nardell E.

Clin Infect Dis. 2011 Feb 15;52(4):554-6. doi: 10.1093/cid/ciq182. No abstract available. Erratum in: Clin Infect Dis. 2012 Nov 15;55(10):1439.

40.

Turning off the spigot: reducing drug-resistant tuberculosis transmission in resource-limited settings.

Nardell E, Dharmadhikari A.

Int J Tuberc Lung Dis. 2010 Oct;14(10):1233-43. Review.

41.

Opportunities afforded by new drugs for tuberculosis.

Churchyard GJ, Friedland G, Fielding K, Nardell E.

Lancet Infect Dis. 2010 Jun;10(6):368-9. doi: 10.1016/S1473-3099(10)70095-5. No abstract available.

PMID:
20510274
42.

Evaluation of the effect of treatment of latent tuberculosis infection on QuantiFERON-TB gold assay results.

Pollock NR, Kashino SS, Napolitano DR, Sloutsky A, Joshi S, Guillet J, Wong M, Nardell E, Campos-Neto A.

Infect Control Hosp Epidemiol. 2009 Apr;30(4):392-5. doi: 10.1086/596606.

43.

Influenza and ultraviolet germicidal irradiation.

Radonovich LJ, Martinello RA, Hodgson M, Milton DK, Nardell EA.

Virol J. 2008 Dec 16;5:149. doi: 10.1186/1743-422X-5-149. No abstract available.

44.

Treatment of extensively drug-resistant tuberculosis in Tomsk, Russia: a retrospective cohort study.

Keshavjee S, Gelmanova IY, Farmer PE, Mishustin SP, Strelis AK, Andreev YG, Pasechnikov AD, Atwood S, Mukherjee JS, Rich ML, Furin JJ, Nardell EA, Kim JY, Shin SS.

Lancet. 2008 Oct 18;372(9647):1403-9. doi: 10.1016/S0140-6736(08)61204-0. Epub 2008 Aug 22.

PMID:
18723218
45.

Discordant QuantiFERON-TB Gold test results among US healthcare workers with increased risk of latent tuberculosis infection: a problem or solution?

Pollock NR, Campos-Neto A, Kashino S, Napolitano D, Behar SM, Shin D, Sloutsky A, Joshi S, Guillet J, Wong M, Nardell E.

Infect Control Hosp Epidemiol. 2008 Sep;29(9):878-86. doi: 10.1086/590262.

46.

What animal models teach humans about tuberculosis.

Dharmadhikari AS, Nardell EA.

Am J Respir Cell Mol Biol. 2008 Nov;39(5):503-8. doi: 10.1165/rcmb.2008-0154TR. Epub 2008 Jun 12. Review.

47.

Safety of upper-room ultraviolet germicidal air disinfection for room occupants: results from the Tuberculosis Ultraviolet Shelter Study.

Nardell EA, Bucher SJ, Brickner PW, Wang C, Vincent RL, Becan-McBride K, James MA, Michael M, Wright JD.

Public Health Rep. 2008 Jan-Feb;123(1):52-60.

48.

Treating multidrug-resistant tuberculosis in Tomsk, Russia: developing programs that address the linkage between poverty and disease.

Keshavjee S, Gelmanova IY, Pasechnikov AD, Mishustin SP, Andreev YG, Yedilbayev A, Furin JJ, Mukherjee JS, Rich ML, Nardell EA, Farmer PE, Kim JY, Shin SS.

Ann N Y Acad Sci. 2008;1136:1-11. Epub 2007 Oct 22.

PMID:
17954675
49.

Tuberculosis infection control in resource-limited settings in the era of expanding HIV care and treatment.

Bock NN, Jensen PA, Miller B, Nardell E.

J Infect Dis. 2007 Aug 15;196 Suppl 1:S108-13. Review.

PMID:
17624819
50.

Tuberculosis and HIV coinfection: current state of knowledge and research priorities.

Friedland G, Churchyard GJ, Nardell E.

J Infect Dis. 2007 Aug 15;196 Suppl 1:S1-3. No abstract available.

PMID:
17624818

Supplemental Content

Loading ...
Support Center